Contents
Editor’s Letter
Fourth and final issue of GaBI Journal’s fourth volume
Commentary
Bioequivalence of narrow therapeutic index drugs and immunosuppressives
Original Research
Perspective
Non-Biological Complex Drugs (NBCDs) and their follow-on versions: time for an editorial section
Opinion
Challenges of developing generics substitution policies in low- and middle-income countries (LMICs)
Meeting Report
Special Report
Patent expiry dates for best-selling biologicals
Supporting biosimilarity and extrapolation
Abstracted Scientific Content
Measuring performance in off-patent drug markets
Immunogenicity assessment of monoclonal antibodies